AB
AllianceBernstein Holding L.P.
AB offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BAC
Bank of America Corporation
BAC has a slight edge over AB overall, supported by stronger fundamentals and stronger modeled upside.
AB Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| N/A | |
| N/A |
AB's profitability is currently strong. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like AB.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
AB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.5x | $33.60 | — |
| Cheap | 10x | $35.15 | +4.6% |
| Current | 10x | $33.60 | — |
| Fair | 12x | $40.78 | +21% |
| Expensive | 14x | $47.54 | +41% |
Historical ranges are pointers, not guarantees.
AB has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
AB Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Strong growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect AB's revenue to grow, but its profitability to weaken.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over AB on the outlook, with more favorable earnings and profitability expectations.
AB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.55 | +6.1% |
| Q3 2026 | $3.35 | +11% |
| Q2 2026 | $3.35 | -0.3% |
| Q1 2026 | $3.22 | -13% |
| Q4 2025 | $2.97 | -20% |
| Q3 2025 | $3.03 | -13% |
| Q2 2025 | $3.36 | +17% |
| Q1 2025 | $3.71 | +53% |
| Q4 2024 | $3.71 | +59% |
AB earned $3.35 per share over the past year, up 11% from the year before.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over AB on earnings, with more consistent year-over-year improvement.
AB Quarterly Revenue
AB and BAC do not have enough comparable growth data to identify a winner.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
AB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $76.4M | +7.2% |
| Q2 2026 | $76.9M | -13% |
| Q1 2026 | $88.5M | -23% |
| Q4 2025 | $77.2M | -12% |
| Q3 2025 | $71.2M | -12% |
| Q2 2025 | $88.7M | +5.2% |
| Q1 2025 | $115.3M | +31% |
| Q4 2024 | $87.5M | +20% |
AB's free cash flow was $319M over the past year, down 12% from the year before. Free cash flow isn't a meaningful measure for financial services companies like AB.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
AB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -1.1M shares |
| 1 year | +1% | +938K shares |
| 3 years | -18% | -19.9M shares |
| 5 years | -6.9% | -6.8M shares |
| Available history | -6.4% | -6.3M shares |
AB has 92M diluted shares, up 1% from a year ago, despite $90M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $38.3M |
| Q2 2026 | $16.9M |
| Q1 2026 | $4.7M |
| Q4 2025 | $29.8M |
| Q3 2025 | $3.9M |
| Q2 2025 | $12.3M |
| Q1 2025 | $26.1M |
| Q4 2024 | — |
AB spent $90M buying back its own shares over the past year, up 112% from the year before.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over AB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
AB Net Leverage
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
AB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.3 | Neutral |
| Stochastic | 13.3 | Oversold |
AB's weekly RSI is 32 (neutral) and its Stochastic is 13 (oversold).
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
AB PE vs Financial Services Sector
| Metric | AB | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 13x | 23% below |
| PE % | 7 | 63 | 56 pts below |
AB has the edge over BAC on valuation relative to its sector.
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
AB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.8 | 3.4% below |
| 20 week MA | $36.0 | 6.7% below |
| 50 week MA | $37.6 | 11% below |
| 100 week MA | $38.3 | 12% below |
| 200 week MA | $36.0 | 6.7% below |
AB is in a downtrend: it's below all five of its weekly moving averages, and 6.7% below its 200-week average.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has the edge over AB on trend strength, trading above more of its moving averages.
AB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.0 | $33.4 | +11% |
| 2021 | $33.4 | $49.0 | +47% |
| 2022 | $49.0 | $34.3 | -30% |
| 2023 | $34.3 | $31.0 | -9.5% |
| 2024 | $31.0 | $37.2 | +20% |
| 2025 | $37.2 | $39.2 | +5.2% |
| 2026 YTD | $39.2 | $33.6 | -14% |
AB has finished higher in four of the last six years. It's down 14% so far in 2026.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over AB on returns for 2026, with the stronger performance.